Neurology ReviewsPatients with MS who consider using marijuana are more likely to engage in risky behaviorsMay 30, 2019Multiple Sclerosis
Clinical Neurology NewsLow baseline heart rate may not increase cardiac risk when starting fingolimodMay 30, 2019Multiple Sclerosis
Clinical Neurology NewsGroup creates three-step algorithm for the management of MS relapseMay 30, 2019Multiple Sclerosis
Neurology ReviewsFingolimod reduces MS disease activity, compared with glatiramer acetateMay 30, 2019Multiple Sclerosis
Clinical Neurology NewsHazardous cannabis use in MS linked to anxiety, depressionMay 30, 2019Multiple Sclerosis
Neurology ReviewsExtended-release arbaclofen reduces MS-related spasticityMay 30, 2019Multiple Sclerosis
Clinical Neurology NewsWhy aren’t preferred DMTs prescribed for MS? Neurologists point to insurers, patientsMay 30, 2019Multiple Sclerosis
Clinical Neurology NewsModest evidence for benefit in studies of cannabis in MSMay 30, 2019Multiple Sclerosis
Clinical Neurology NewsMore patients than ever receive DMT within 1 year of MS disease onsetMay 28, 2019Multiple Sclerosis
Neurology ReviewsPain, fatigue, depression, and anxiety are common in the year after MS diagnosisMay 28, 2019Multiple SclerosisPain
Neurology ReviewsAge may influence choice of behavioral therapy to improve sleep in MSMay 28, 2019Multiple SclerosisSleep Medicine
Clinical Neurology NewsGeneral neurologists lag on prescribing high-efficacy MS drugsMay 28, 2019Multiple Sclerosis
Neurology ReviewsPeriodic limb movements during sleep are common in patients with MS and fatigueMay 28, 2019Multiple SclerosisSleep Medicine
